103 results on '"Price, Richard"'
Search Results
2. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
3. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19.
4. Exosomal MicroRNAs Associate With Neuropsychological Performance in Individuals With HIV Infection on Antiretroviral Therapy.
5. Investigating the Relationship of the Functional Gait Assessment to Spatiotemporal Parameters of Gait and Quality of Life in Individuals With Stroke.
6. CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection.
7. No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts.
8. Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive Cases.
9. Relationship Between HIV Infection, Antiretroviral Therapy, Inflammatory Markers, and Cerebrovascular Endothelial Function Among Adults in Urban China.
10. Putamen volume and its clinical and neurological correlates in primary HIV infection.
11. Selective decontamination of the digestive tract and oropharynx: after 30 years of debate is the definitive answer in sight?
12. Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals.
13. Mechanisms of Amplified Arteriogenesis in Collateral Artery Segments Exposed to Reversed Flow Direction.
14. Cerebral white matter integrity during primary HIV infection.
15. Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection.
16. Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection.
17. Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection.
18. Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.
19. Peripheral Neuropathy in Primary HIV Infection Associates With Systemic and Central Nervous System Immune Activation.
20. Squamous cell carcinoma of the temporal bone: clinical outcomes from radical surgery and postoperative radiotherapy.
21. Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers.
22. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.
23. Acoustic Attenuation by Contrast Agent Microbubbles in Superficial Tissue Markedly Diminishes Petechiae Bioeffects in Deep Tissue.
24. Antiretroviral Treatment Effect on Immune Activation Reduces Cerebrospinal Fluid HIV-1 Infection.
25. Persistent Intrathecal Immune Activation in HIV-1—Infected Individuals on Antiretroviral Therapy.
26. Comparison of 1-site versus 2-site phacotrabeculectomy
27. Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy.
28. Undetectable Cerebrospinal Fluid HIV RNA and ²-2 Microglobulin Do Not Indicate Inactive AIDS Dementia Complex in Highly Therapy—Treated Patients.
29. T-Cell Activation and Memory Phenotypes in Cerebrospinal Fluid During HIV Infection.
30. HIV-Producing T Cells in Cerebrospinal Fluid.
31. Enhanced Smooth Muscle Cell Coverage of Microvessels Exposed to Increased Hemodynamic Stresses In Vivo.
32. HIV-Related Neuropathology, 1985 to 1999: Rising Prevalence of HIV Encephalopathy in the Era of Highly Active Antiretroviral Therapy.
33. Stimulation of arteriogenesis in skeletal muscle by microbubble destruction with ultrasound.
34. HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir.
35. Early HIV-1 infection and the AIDS dementia complex.
36. Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force.
37. Enhanced regional uptake of 2-deoxy-D- [14C] glucose in focal herpes simplex type 1 encephalitis.
38. Progressive multifocal leukoencephalopathy (PML).
39. Immunohistochemical Identification of Arteriolar Development Using Markers of Smooth Muscle Differentiation Evidence That Capillary Arterialization Proceeds From Terminal Arterioles.
40. Low Back and Sciatic Pain.
41. The findings of the International Conference on Medical Emergency Teams are biased and misleading.
42. Surgical cricothyroidotomy technique.
43. Regional Cerebral Glucose Metabolism in AIDS Dementia.
44. Impairment of Smooth Pursuit Eye-Tracking in Human Immunodeficiency Virus Infection and Its Relationship to AIDS Dementia Complex.
45. Dissociation of AIDS-Related Vacuolar Myelopathy (VM) and Productive Human Immunodeficiency Virus Type 1 (HIV-1) Infection of the Spinal Cord.
46. Cerebrospinal Fluid (CSF) Beta-2 Microglobulin (β2M) in Patients Infected with Human Immunodeficiency Virus Type 1 (HIV-1).
47. AIDS-Related Vacuolar Myelopathy (VM) is not Associated with Co-infection by Human T-Lymphotropic Virus Type One (HTLV-1).
48. Transfusion-Related Human T-Lymphotropic Virus Type 1 (HTLV-1)-Associated Myelopathy (HAM).
49. Vacuolar Myelopathy in Patients with the Acquired Immune Deficiency Syndrome (AIDS).
50. AIDS Dementia: Clinical-Pathological Analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.